Flip Distribution Alignment VAE for Multi-Phase MRI Synthesis
Xiaoyan Kui, Qianmu Xiao, Qqinsong Li, Zexin Ji, JIelin Zhang, Beiji Zou
TL;DR
This paper tackles multi-phase CE MRI synthesis by explicitly decoupling shared and phase-specific latent features using a lightweight variational autoencoder. It introduces Flip Distribution Alignment (FDA) to enforce symmetry of latent distributions around a standard normal and employs a Y-shaped bidirectional training strategy to enable both self-reconstruction and cross-phase synthesis with simple mean-flipping. The approach achieves superior synthesis quality while significantly reducing model size and inference time compared with state-of-the-art deep autoencoders, demonstrated on a liver MRI dataset with six synthesis tasks. These characteristics imply practical impact for faster, safer MRI workflows with limited annotated data. The method combines a compact VAE backbone, structured latent space constraints, and bidirectional training to deliver interpretable and efficient multi-phase image synthesis.
Abstract
Separating shared and independent features is crucial for multi-phase contrast-enhanced (CE) MRI synthesis. However, existing methods use deep autoencoder generators with low parameter efficiency and lack interpretable training strategies. In this paper, we propose Flip Distribution Alignment Variational Autoencoder (FDA-VAE), a lightweight feature-decoupled VAE model for multi-phase CE MRI synthesis. Our method encodes input and target images into two latent distributions that are symmetric concerning a standard normal distribution, effectively separating shared and independent features. The Y-shaped bidirectional training strategy further enhances the interpretability of feature separation. Experimental results show that compared to existing deep autoencoder-based end-to-end synthesis methods, FDA-VAE significantly reduces model parameters and inference time while effectively improving synthesis quality. The source code is publicly available at https://github.com/QianMuXiao/FDA-VAE.
